Robert J. Bitterman
President and Chief Executive Officer at Phio Pharmaceuticals.
Earliest Form D on file: Jan 2025
5 filings at 1 company
Biotech, Marlborough MA
President and Chief Executive Officer · signer
- Signed
- Named
- Size is amount sold, up to $30M
Filings
5- Nov 12, 2025
Option to acquire, security to be acquired, signed · Form D
$1.4M
of $25.9M
Nov 12, 2025Option to acquire, security to be acquired
Signed as President and Chief Executive Officer
$1.4M
$25.9M
- Aug 4, 2025
Option to acquire, security to be acquired, signed · Form D
$232K
of $5.1M
Aug 4, 2025Option to acquire, security to be acquired
Signed as President and Chief Executive Officer
$232K
$5.1M
- Jan 28, 2025
Option to acquire, security to be acquired, signed · Form D
$153K
of $3.66M
Jan 28, 2025Option to acquire, security to be acquired
Signed as President and Chief Executive Officer
$153K
$3.66M
- Jan 28, 2025
Option to acquire, security to be acquired, signed · Form D
$208K
of $5M
Jan 28, 2025Option to acquire, security to be acquired
Signed as President and Chief Executive Officer
$208K
$5M
- Jan 28, 2025
Option to acquire, security to be acquired, signed · Form D
$266K
of $6.4M
Jan 28, 2025Option to acquire, security to be acquired
Signed as President and Chief Executive Officer
$266K
$6.4M
Network
At Phio Pharmaceuticals
7 people- Together on 5 filings
Director
- Together on 5 filings
Director
- Together on 5 filings
Director
- Together on 4 filings
Director
- Together on 3 filings
Executive Officer, Promoter
- Together on 2 filings
Director